MedPath

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart Failure

Recruiting
Conditions
Heart Failure
Registration Number
NCT05672719
Lead Sponsor
Mount Sinai Hospital, Canada
Brief Summary

The goal of this observational study is to learn about heart function and high lung blood pressure in patients with heart failure. The main question\[s\] it aims to answer are whether we can improve the ability to predict patients who will have complications after they receive treatment including heart transplant and left ventricular assist devices.

Detailed Description

Prospective cohort study of patients with heart failure with reduced ejection fraction that are referred for diagnostic right heart catheterization as part of their evaluation for candidacy for advanced heart failure therapies.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
74
Inclusion Criteria
  • Adults age 18 years or older
  • Heart failure with reduced ejection fraction (<40%)
  • referred for RHC at our centre for evaluation of candidacy for advanced HF therapies.
Exclusion Criteria

Severe valvular or complex congenital heart disease Short-term mechanical circulatory support for progressive cardiogenic shock (e.g. extracorporeal membrane oxygenation) Acute coronary syndrome or revascularization occurred within 7 days prior to the RHC.

Pregnant or breast-feeding Known hypersensitivity to sodium nitroprusside Advanced liver dysfunction Reduced capacity or inability to provide informed consent

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
right ventricular end systolic elastanceFirst study 1 day visit

Hemodynamic measurement

pulmonary arterial elastanceFirst study 1 day visit

hemodynamic measurement

Mean pulmonary artery pressureFirst study 1 day visit

Hemodynamic measurement

Secondary Outcome Measures
NameTimeMethod
Right ventricular failure after heart transplant1 year

Clinical outcome

Right ventricular failure after left ventricular assist device1 year

Clinical outcome

Trial Locations

Locations (1)

Mount Sinai Hospital

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath